ASH 46th (2004)

Title Content type
Treatment of Resistant Leukemia by rIL-2 Activated NK Cells in Recipients of HLA Matched and Haploidentically Mismatched Stem Cell Allografts while Avoiding GVHD. (click for details)
Low Frequency of Donor-Derived Neuronal, Glia, and Endothelial Cells in the Cerebellum of Patients Undergoing Sex-Mismatched Bone Marrow Transplantation. (click for details)
Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study. (click for details)
Allogeneic Transplantation for Acute Myeloid Leukemia (AML) M2 with Translocation (8;21) and CD56 Positivity Is Effective Even for Patients with Relapsed Disease. (click for details)
Hospital Resource Utilization in Acute Invasive Aspergillosis (AIA) Patients (Pts) Treated with Voriconazole (VOR) or Amphotericin B (CAB) (click for details)
Allogenic Peripheral Blood Stem Cell Transplant Utilizing Rabbit Anti-Thymocyte Globulin as a Part of Non-Myeloablative Conditioning Therapy. (click for details)
Vincristine-Laden Platelets Can Improve Platelet Counts in Patients with Refractory Thrombocytopenia. (click for details)
Impact of Immunosuppressive Drugs on Adaptive and Innate Immune Responses to Aspergillus fumigatus Antigens. (click for details)
Dose Dense, High Intensity Therapy in Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia Using Gemtuzumab Ozogamicin (Mylotarg8482;) and High Dose Cytarabine (HiDAC). (click for details)
Emergence of Mucormycosis in Onco-Hematology after Prolonged Use of Voriconazole: Attention Required. (click for details)

Pages

Subscribe to ASH 46th (2004)